Sound Income Strategies’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-70
Closed -$884 1523
2024
Q3
$884 Hold
70
﹤0.01% 1259
2024
Q2
$886 Hold
70
﹤0.01% 1221
2024
Q1
$335 Hold
70
﹤0.01% 1269
2023
Q4
$336 Buy
70
+20
+40% +$122 ﹤0.01% 1249
2023
Q3
$362 Hold
50
﹤0.01% 1091
2023
Q2
$372 Hold
50
﹤0.01% 1051
2023
Q1
$347 Hold
50
﹤0.01% 1016
2022
Q4
$514 Hold
50
﹤0.01% 904
2022
Q3
$1K Hold
50
﹤0.01% 814
2022
Q2
$3K Hold
50
﹤0.01% 661
2022
Q1
$4K Hold
50
﹤0.01% 631
2021
Q4
$7K Hold
50
﹤0.01% 538
2021
Q3
$10K Hold
50
﹤0.01% 458
2021
Q2
$11K Buy
+50
New +$9.16K ﹤0.01% 460

Other funds holding NVAX

Sound Income Strategies's NVAX Position: Q4 2024 in Review

Sound Income Strategies sold out of Novavax (NVAX) in Q4 2024, closing a stake of 70 shares — an estimated $884 sold.

Sound Income Strategies first reported a position in NVAX in Q2 2021 and held it in 14 quarters. The position peaked at $11K in Q2 2021. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Sound Income Strategies reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Sound Income Strategies sold 70 Novavax shares in Q4 2024, an estimated $884.
  • Sound Income Strategies first reported a position in Novavax in Q2 2021 and held it in 14 quarters.
  • Sound Income Strategies's Novavax position peaked at $11K in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Sound Income Strategies's 13F filing for Q4 2024, filed 21 Jan 2025.